Observes HIV and other infections to learn who gets them
Part of Immune system & allergy, Infections clinical trials.
This is an observational study that follows people to better understand how HIV and other infections (like sexually transmitted infections) happen and change over time. It may help researchers improve prevention and care, but it is mainly for monitoring rather than testing a new treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 14 and 55 years old
- Your screening HIV test must be negative at enrollment (Step 1)
- You can and will sign consent, and you can follow the study for the planned time
- You must be willing to share contact info (you and one trusted person) and be reachable
- You may qualify if you have recent STI diagnoses or certain HIV risk situations in the past 24 weeks
- You should be able to do HIV/STI testing and answer questions about risk behaviors
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This is an observational study (not a new drug) that tracks how living with HIV can change over time in different treatment situations. It may help researchers understand long-term effects of the modern “protease inhibitor era” and improve future care.
This is an observational study that follows people with HIV who are taking HIV medicines (antiretroviral therapy). It may help researchers understand how treatment is going and what factors relate to doing well on therapy.
This study tests whether getting HIV care through a community program is as helpful as going to a clinic for people who just found out they have HIV. It looks at how well they stay in care and take their medicine.
This study looks at the types of germs that cause infections in people with HIV. It aims to help doctors better understand and treat these infections.
This study tests an experimental medication in healthy volunteers to see how it is processed by the body and whether it is safe. You may not receive direct benefit, but your participation helps find better treatments for people with HIV.
This registry study looks at people who are HIV-negative but at high risk of getting HIV, to better understand risk and care needs. If you qualify, you may be asked to share health and behavior information to help guide future prevention efforts.
Hear when a new HIV Infections trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.